Molecular Templates, Inc. (MTEM) Social Stream
MOLECULAR TEMPLATES INC (MTEM) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering MTEM.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-19 | 6 | $18 | $12 | $13.6 | $0.535 | 2442.06% |
| 2021-12-02 | 6 | $14 | $9 | $11.75 | $0.535 | 2096.26% |
| 2022-03-09 | 5 | $14 | $9 | $11.75 | $0.535 | 2096.26% |
| 2022-03-28 | 4 | $14 | $9 | $11.5 | $0.535 | 2049.53% |
| 2022-03-30 | 5 | $14 | $4.5 | $9.9 | $0.535 | 1750.47% |
| 2022-05-12 | 5 | $14 | $4.5 | $9.5 | $0.535 | 1675.7% |
| 2022-05-13 | 5 | $14 | $4.5 | $9.1 | $0.535 | 1600.93% |
| 2022-07-18 | 5 | $14 | $1.5 | $7.6 | $0.535 | 1320.56% |
| 2022-08-11 | 5 | $12 | $1.5 | $7.2 | $0.535 | 1245.79% |
| 2022-09-17 | 5 | $12 | $1.5 | $6.4 | $0.535 | 1096.26% |
| 2023-01-26 | 5 | $12 | $1 | $5.875 | $0.535 | 998.13% |
The Trend in the Analyst Price Target
Over the past 23 months, MTEM's average price target has gone down $13.38.
MTEM reports an average of 582.8% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-09 | 4 | 14 | 9.0 | 11.750 | 2.550 | 360.78% |
| 2022-03-09 | 5 | 14 | 9.0 | 11.750 | 2.550 | 360.78% |
| 2022-05-13 | 5 | 14 | 4.5 | 9.100 | 1.240 | 633.87% |
| 2022-07-18 | 5 | 14 | 1.5 | 7.600 | 1.000 | 660% |
| 2023-01-26 | 5 | 12 | 1.0 | 5.875 | 0.528 | 1012.69% |
MTEM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.6 | 4 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
MTEM's average broker recommendation rating worsened by 0.6 over the prior 35 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, MOLECULAR TEMPLATES INC's upside potential (average analyst target price relative to current price) is higher than 1476.95% of them.
- In terms of how MOLECULAR TEMPLATES INC fares relative to all US stocks, note that its average analyst price target is higher than 153.58% of that group.
- MTEM has a lower variance in analysts' estimates than -771.25% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, MOLECULAR TEMPLATES INC's number of analysts covering the stock is higher than 469.68% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to MOLECULAR TEMPLATES INC are SVRA, BPTH, and GALT.
View All Top Stocks by Price Target
Make investment decisions regarding MTEM using the data that counts. Try POWR Ratings for free.